Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Jan;74(1):329–333. doi: 10.1073/pnas.74.1.329

Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.

W E Biddison, J C Palmer
PMCID: PMC393253  PMID: 402006

Abstract

The immune reactivity to tumor cells within a progressively growing tumor mass in the syngeneic host has been analyzed by studying the cell-mediated cytolytic response of DBA/2 mice to the ascitic mastocytoma P815Y. Peritoneal cells from P815Y tumor-bearing hosts were fractionated by velocity sedimentation at unit gravity. Cell-mediated cytotoxicity of fractionated and unfractionated cells was measured by 51Cr-release from tumor target cells. The cell separation procedure revealed significant levels of specific cell-mediated cytotoxicity to P815Y within peritoneal cell populations at 8-16 days after tumor cell inoculation. Tumor cells purified from the peritoneal cell populations of mice injected with 10(3) tumor cells 10 days previously were as susceptible to syngeneic and allogeneic cell-mediated cytotoxicity as P815Y grown in vitro. However, tumor cells obtained from mice 16 days after tumor inoculation were resistant to cytolysis by syngeneic, but not allogeneic, effector cells. In addition, day 16 tumor cells did not inhibit syngeneic cell-mediated cytotoxicity against P815Y grown in vitro. Immunoglobulin was not detected on day 16 tumor cells and no circulating antibody to P815Y was found in the ascitic fluid of day 16 tumor-bearing mice. These results indicate that tumor cells may escape immune attack by loss of expression of cell surface tumor-associated antigens in the absence of circulating antibody against tumor.

Full text

PDF
329

Images in this article

330Image
on p.330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Johnson P. A. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation. J Natl Cancer Inst. 1972 Jul;49(1):183–192. [PubMed] [Google Scholar]
  2. Boyse E. A., Stockert E., Old L. J. Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A. 1967 Sep;58(3):954–957. doi: 10.1073/pnas.58.3.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  4. Evans C. H., Ohanian S. H., Cooney A. M. Tumor-specific and forssman antigens of guinea-pig hepatoma cells: comparison of tumor cells grown in vivo and in vitro. Int J Cancer. 1975 Mar 15;15(3):512–521. doi: 10.1002/ijc.2910150317. [DOI] [PubMed] [Google Scholar]
  5. Faanes R. B., Choi Y. S. Interaction of isoantibody and cytotoxic lymphocytes with allogeneic tumor cells. J Immunol. 1974 Jul;113(1):279–288. [PubMed] [Google Scholar]
  6. Fenyö E. M., Klein E., Klein G., Swiech K. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. J Natl Cancer Inst. 1968 Jan;40(1):69–89. [PubMed] [Google Scholar]
  7. Fujimoto S., Greene M. I., Sehon A. H. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):791–799. [PubMed] [Google Scholar]
  8. Gershon R. K., Mokyr M. B., Mitchell M. S. Activation of suppressor T cells by tumour cells and specific antibody. Nature. 1974 Aug 16;250(467):594–596. doi: 10.1038/250594a0. [DOI] [PubMed] [Google Scholar]
  9. Goldstein L. T., Klinman N. R., Manson L. A. A microtest radioimmunoassay for noncytotoxic tumor-specific antibody to cell-surface antigens. J Natl Cancer Inst. 1973 Nov;51(5):1713–1715. doi: 10.1093/jnci/51.5.1713. [DOI] [PubMed] [Google Scholar]
  10. Haskill J. S., Proctor J. W., Yamamura Y. Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas. J Natl Cancer Inst. 1975 Feb;54(2):387–393. [PubMed] [Google Scholar]
  11. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  12. Herberman R. B. Cell-mediated immunity to tumor cells. Adv Cancer Res. 1974;19(0):207–263. doi: 10.1016/s0065-230x(08)60055-x. [DOI] [PubMed] [Google Scholar]
  13. Kirchner H., Chused T. M., Herberman R. B., Holden H. T., Lavrin D. H. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med. 1974 Jun 1;139(6):1473–1487. doi: 10.1084/jem.139.6.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lesley J., Hyman R., Dennert G. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation. J Natl Cancer Inst. 1974 Dec;53(6):1759–1765. [PubMed] [Google Scholar]
  15. Manson L. A., Palmer J. C. Induction of the immune response to cell surface antigens in vitro. In Vitro. 1975 Jul-Aug;11(4):186–204. doi: 10.1007/BF02616334. [DOI] [PubMed] [Google Scholar]
  16. Miller R. G., Phillips R. A. Separation of cells by velocity sedimentation. J Cell Physiol. 1969 Jun;73(3):191–201. doi: 10.1002/jcp.1040730305. [DOI] [PubMed] [Google Scholar]
  17. OLD L. J., BOYSE E. A. ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS. J Natl Cancer Inst. 1963 Oct;31:977–995. [PubMed] [Google Scholar]
  18. Old L. J., Boyse E. A., Geering G., Oettgen H. F. Serologic approaches to the study of cancer in animals and in man. Cancer Res. 1968 Jul;28(7):1288–1299. [PubMed] [Google Scholar]
  19. Old L. J., Stockert E., Boyse E. A., Kim J. H. Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med. 1968 Mar 1;127(3):523–539. doi: 10.1084/jem.127.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ortaldo J. R., Ting C. C., Herberman R. B. Modulation of fetal antigen(s) in mouse leukemia cells. Cancer Res. 1974 Jun;34(6):1366–1371. [PubMed] [Google Scholar]
  21. Prehn R. T. Do tumors grow because of the immune response of the host? Transplant Rev. 1976;28:34–42. doi: 10.1111/j.1600-065x.1976.tb00191.x. [DOI] [PubMed] [Google Scholar]
  22. Sanford B. H. An alteration in tumor histocompatibility induced by neuraminidase. Transplantation. 1967 Sep 5;5(5):1273–1279. doi: 10.1097/00007890-196709000-00005. [DOI] [PubMed] [Google Scholar]
  23. Shellam G. R., Knight R. A. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells. Nature. 1974 Nov 22;252(5481):330–332. doi: 10.1038/252330a0. [DOI] [PubMed] [Google Scholar]
  24. Stackpole C. W., Jacobson J. B., Lardis M. P. Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes. J Exp Med. 1974 Oct 1;140(4):939–953. doi: 10.1084/jem.140.4.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Thorn R. M., Palmer J. C., Manson L. A. A simplified 51Cr-release assay for killer cells. J Immunol Methods. 1974 Mar;4(2):301–315. doi: 10.1016/0022-1759(74)90073-8. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES